CORC  > 上海药物研究所  > 中国科学院上海药物研究所
The discovery of novel small molecular CXCR2 antagonist by using ligand-based pharmacophore model
Huang, Wen-Hai1; Wang, Zhi-Long2; Che, Jin-Xin3; Sheng, Hai-Chao3; Huang, Feng3; Hu, Yong-Zhou3; Hu, You-Hong2; Xie, Xin4; Dong, Xiao-Wu3
刊名CANCER RESEARCH
2018-07-01
卷号78期号:13页码:2
ISSN号0008-5472
DOI10.1158/1538-7445.AM2018-LB-064
WOS研究方向Oncology
语种英语
出版者AMER ASSOC CANCER RESEARCH
WOS记录号WOS:000468818900230
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/289599]  
专题中国科学院上海药物研究所
作者单位1.Zhejiang Acad Med Sci, Inst Mat Med, Hangzhou, Zhejiang, Peoples R China
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai, Peoples R China
3.Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China
4.Chinese Acad Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Huang, Wen-Hai,Wang, Zhi-Long,Che, Jin-Xin,et al. The discovery of novel small molecular CXCR2 antagonist by using ligand-based pharmacophore model[J]. CANCER RESEARCH,2018,78(13):2.
APA Huang, Wen-Hai.,Wang, Zhi-Long.,Che, Jin-Xin.,Sheng, Hai-Chao.,Huang, Feng.,...&Dong, Xiao-Wu.(2018).The discovery of novel small molecular CXCR2 antagonist by using ligand-based pharmacophore model.CANCER RESEARCH,78(13),2.
MLA Huang, Wen-Hai,et al."The discovery of novel small molecular CXCR2 antagonist by using ligand-based pharmacophore model".CANCER RESEARCH 78.13(2018):2.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace